The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
Claire X Y GohYing Kiat TanChoon Han TanAloysius S T LeowJamie S Y HoNatalie H W TanSherill GohAndrew F W HoVijay K SharmaBernard P L ChanLeonard Leong-Litt YeoBenjamin Y Q TanPublished in: Journal of thrombosis and thrombolysis (2022)
The use of colchicine reduces the risk of stroke in patients with a history of coronary artery disease, without a significant increase in gastrointestinal and myopathy/myalgia adverse effects.